Utilization and Perioperative Outcomes of Partial Cystectomy for Urothelial Carcinoma of the Bladder: Lessons from the ACS NSQIP Database

2015 ◽  
Vol 2 (3) ◽  
pp. 109-114
Author(s):  
Michael J. Whalen ◽  
Matthew R. Danzig ◽  
Jamie S. Pak ◽  
Blake D. Alberts ◽  
Ketan K. Badani ◽  
...  
2009 ◽  
Vol 181 (4S) ◽  
pp. 126-126
Author(s):  
Umberto Capitanio ◽  
Hendrik Isbarn ◽  
Shahrokh F Shariat ◽  
Claudio Jeldres ◽  
Laurent Zini ◽  
...  

Urology ◽  
2009 ◽  
Vol 74 (4) ◽  
pp. 858-864 ◽  
Author(s):  
Umberto Capitanio ◽  
Hendrik Isbarn ◽  
Shahrokh F. Shariat ◽  
Claudio Jeldres ◽  
Laurent Zini ◽  
...  

2015 ◽  
Vol 14 (2) ◽  
pp. e337-e337a
Author(s):  
J. Hanske ◽  
A. Sanchez ◽  
C.P. Meyer ◽  
M. Schmid ◽  
F. Roghmann ◽  
...  

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Michael Leveridge ◽  
D Robert Siemens ◽  
Jason Izard ◽  
Xuejiao Wei ◽  
William Mackillop ◽  
...  

Vascular ◽  
2019 ◽  
Vol 27 (6) ◽  
pp. 653-662 ◽  
Author(s):  
Arash Fereydooni ◽  
Bin Zhou ◽  
Saman Doroodgar Jorshery ◽  
Yanhong Deng ◽  
Alan Dardik ◽  
...  

Objectives Despite reports of increasing use of hybrid surgery for lower extremity revascularization in Europe, little is known about the performance of hybrid procedures in the U.S. This study aims to investigate contemporary national trends in frequency and operator distribution of hybrid lower extremity revascularization and compare the perioperative outcomes of independent vascular surgeons and other surgical specialists. We hypothesized that hybrid procedures are increasingly performed, and independent vascular surgeons have superior outcomes compared to other surgical specialists. Methods The 2005–2015 American College of Surgeons National Surgical Quality Improvement Project (ACS-NSQIP) database was used to identify patients undergoing open or hybrid lower extremity revascularization based on Current Procedural Terminology codes. Only patients treated for peripheral artery disease, based on International Classification of Diseases codes-9, were included. A trend of yearly hybrid lower extremity revascularization compared to open lower extremity revascularization was obtained. The most commonly performed hybrid procedure was identified as well as the specialties of the primary operators. Operators were categorized as “independent vascular surgeons” and “other surgeons” if the primary operator was a non-vascular surgeon or a vascular surgeon assisted by a second specialist as part of a team. Patients undergoing this hybrid lower extremity revascularization by independent vascular surgeons were selected and matched (2:1) to the patients who underwent the same procedure by other surgical specialists. Matching was based on age, gender, functional status, American Society of Anesthesiologists classification, transfer status, emergent surgery, and indication. The characteristics and perioperative outcomes of those two groups were compared. Results The overall rate of hybrid procedures increased from 4% in 2005 to 14% in 2015 ( p < 0.0001). During this period, vascular surgeons independently performed 92.9% of all hybrid surgeries, with no significant change in the yearly trend ( p = 0.15). Femoral endarterectomy with retrograde aortoiliac intervention was identified as the most common procedure, accounting for 35.7% and 33.3% of hybrid lower extremity revascularization performed by independent vascular surgeons and other surgeons, respectively. After propensity matching, there were 212 patients treated by independent vascular surgeons and 106 patients treated by other surgeons, with no significant difference in demographics or comorbidities. There was no difference between independent vascular surgeons and other surgeons in mortality (1.4% and 2.8%, respectively, p = 0.30), overall morbidity (19.3% and 18.9% respectively, p = 0.91), and other complications. Conclusion Hybrid lower extremity revascularization for peripheral artery disease has been increasingly used and is performed primarily by independent vascular surgeons. Simple hybrid procedures may be performed safely by vascular surgeons as well as other trained surgical specialists.


2006 ◽  
Vol 175 (6) ◽  
pp. 2058-2062 ◽  
Author(s):  
Wassim Kassouf ◽  
David Swanson ◽  
Ashish M. Kamat ◽  
Dan Leibovici ◽  
Arlene Siefker-Radtke ◽  
...  

2017 ◽  
Vol 11 (12) ◽  
pp. 412-8 ◽  
Author(s):  
Michael J. Leveridge ◽  
D. Robert Siemens ◽  
Jason P. Izard ◽  
Xuejiao Wei ◽  
Christopher M. Booth

Introduction: Partial cystectomy (PC) for urothelial carcinoma (UC) in selected patients may avoid the morbidity of radical cystectomy (RC). We describe use and outcomes of PC for UC in routine clinical practice.Methods: All patients with urothelial carcinoma of the bladder (UCB) undergoing PC or RC in Ontario from 1994‒2008 were identified using the Ontario Cancer Registry and linked electronic records. Pathology reports were reviewed. Variables associated with PC use were identified using logistic regression. Cox proportional hazards model identified factors affecting cancer-specific (CSS) and overall survival (OS).Results: A total of 3320 patients underwent PC (n=181; 5%) or RC (n=3139; 95%) from 1994‒2008. PC patients were older (36% 80+ years vs. 19%; p<0.001) and more likely to have organ-confined (&lh;pT3) disease (54% vs. 36% RC; p<0.001). Two-thirds (67%) of PC patients did not undergo lymph node dissection (24% for RC; p<0.001). Factors associated with having PC included older age (odds ratio [OR] 1.55; 95% confidence interval [CI] 0.96‒2.51 for 70+ years), moderate comorbidity (OR 1.95; 95% CI 1.13‒3.37), and surgery outside of a comprehensive cancer centre (OR 1.44; 95% CI 1.03‒2.01). Unadjusted five-year OS for PC and RC cases was 34% and 33%, respectively (p=0.455); CSS at five years was 43% and 37% (p=0.045). On adjusted analysis, PC was associated with comparable CSS (hazard ratio [HR] 0.87, 95% CI 0.70‒1.09) and OS (HR 0.95, 95% CI 0.79‒1.14) as RC.Conclusions: In routine clinical practice, PC is not common. A substantial proportion of patients treated with PC achieve longterm survival. PC remains a treatment option in selected patients with UCB.


2012 ◽  
Vol 111 (3b) ◽  
pp. E37-E42 ◽  
Author(s):  
Harman M. Bruins ◽  
Ross Wopat ◽  
Anirban P. Mitra ◽  
Jie Cai ◽  
Gus Miranda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document